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Edited by Jesus AvilaAbstract Due to their structural characteristics and their diver-
sity, the 22 members of the protocadherin-gamma (Pcdhc) fam-
ily have been suggested to contribute to the establishment of
speciﬁc connections in the nervous system. Here, we focus on a
single isoform, Pcdhc-b1. Its expression is found in diﬀerent
brain regions and in developing spinal cord it is restricted to scat-
tered cells, whereas all cells are labeled using an antibody that
recognizes all Pcdhc isoforms. As a ﬁrst step to understanding
the signaling mechanisms downstream of Pcdhc, we identify
the microtubule-destabilizing protein SCG10 as a cytoplasmic
interactor for Pcdhc-b1 and other isoforms of the Pcdhc-b sub-
family, and show that SCG10 and Pcdhc-b1 are found together
in certain neuronal growth cones.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The large number of protocadherins (Pcdhs) and their
diversity and high expression levels in neural tissue suggest
that they might provide a molecular code involved in estab-
lishing complex networks of neuronal connections [1–3].
Analysis of the expression of the entire Protocadherin-gam-
ma (Pcdhc) family shows that Pcdhc proteins in neurons are
localized both in growth cones [4] and at synapses [5]. Fur-
thermore, mice homozygous for deletion of the Pcdhc locus
die at birth and show extensive apoptotic death of interneu-
rons in the spinal cord, possibly resulting from erroneous
synapse formation [6].
Pcdhs are transmembrane proteins: their extracellular do-
main comprises a variable number of cadherin ectodomains
but their cytoplasmic domain has no similarity with the cad-
herin intracellular domain (for review, see [7]). The major
part of each of the 22 Pcdhc isoforms is encoded by a single
large ‘‘variable’’ exon, which is spliced to three short down-
stream ‘‘constant’’ exons [8,9]. The resulting proteins diﬀer*Corresponding author. Fax: +33 491 26 97 57.
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doi:10.1016/j.febslet.2004.10.096in their extracellular and transmembrane domains and in
ﬁrst part of their cytoplasmic domains, but share an identi-
cal C-terminal cytoplasmic domain (Fig. 1A). On the basis
of their sequences, Pcdhc isoforms may be further subdi-
vided into three subclasses – a, b and c – comprising 12,
7 and 3 members, respectively [3]. The variable portion of
the cytoplasmic domains of Pcdhc isoforms diﬀers between
subclasses, suggesting that each subclass might interact with
characteristic downstream eﬀectors. This might provide a
means by which diﬀerent subclasses regulate diﬀerent cellular
functions. However, nothing is currently known of the sig-
naling capacities of the Pcdhc isoforms.
The b subfamily is of particular interest because the cyto-
plasmic variable domains of these isoforms contain a short
conserved sequence including two tyrosine residues, which rep-
resent potential sites of post-translational regulation. We have
performed a two-hybrid screen to identify putative down-
stream eﬀectors. We show here that the cytoplasmic domain
of Pcdhc-b1 interacts with SCG10, a protein present in growth
cones that is involved in the control of microtubule polymeri-
zation during neuronal diﬀerentiation.2. Materials and methods
2.1. Antibodies
To raise antibodies speciﬁc to the mouse Pcdhc-b1 isoform, the
variable intracellular region was used as an antigen. It was pro-
duced in Escherichia coli BL21-RIL as a GST fusion protein ex-
pressed from pGEX-6P vector, puriﬁed and separated from the
GST moiety by endoprotease cleavage. Rabbits were immunized
with the puriﬁed protein at Eurogentec and speciﬁc antibodies
were puriﬁed from the serum by aﬃnity puriﬁcation with a His-
tag fusion of the variable intracellular region of Pcdhc-b1 cross-
linked to a Sepharose column (Pharmacia). Pan-Pcdhc antibodies
were described previously [4], serum against SCG10 [10] was a gift
of Dr. A. Sobel. a-Tubulin was detected using mouse monoclonal
antibody DM1A (Sigma).
Western blot analysis was performed as described previously [11]
using chemiluminescence with ECL or ECL Plus kit (Amersham),
depending on the sensitivity required.2.2. Two-hybrid screening
Yeast two-hybrid analysis was carried out using the Matchmaker
Gal4 Two-Hybrid System3 (Clontech) according to the manufacturers
instructions. Selection of interactors used only histidine and adenine
auxotrophy selection. The bait vector was constructed by PCR ampli-
ﬁcation and in-frame cloning of the Pcdhc-b1 cDNA region corre-
sponding to nucleotides 2271–2549 (GenBank BC054741) in
pGBKT7-BD vector and veriﬁed by sequencing. A pre-existing libraryation of European Biochemical Societies.
Fig. 1. Pcdhc-b1 structure and antibodies validation. (A) Schematic
representation of Pcdhc. The extracellular and transmembrane
domains, and the ﬁrst part of the cytoplasmic domains, are diﬀerent
for each Pcdhc isoform while the C-terminal cytoplasmic tail is
identical for all isoforms. The variable part of the cytoplasmic domain
was used to generate isoform speciﬁc antibodies against Pcdhc-b1. It
also served as bait in the two-hybrid screen and as GST fusion for the
in vitro interaction assay. (B) The puriﬁed antibodies were tested by
Western blotting on extracts of cortex and mock-transfected COS-7
cells or COS-7 cells transfected with Pcdhc-b1, as negative and positive
controls, respectively.
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cloned in pGADT7-AD vector. As negative controls, bait vector with
lamin and SMN inserts was used.
2.3. Production of GST fusion proteins and in vitro veriﬁcation of
interactions
The cDNA sequence corresponding to the variable cytoplasmic do-
mains of Pcdhc-b1, Pcdhc-b2, Pcdhc-b8 and Pcdh c-c4 was cloned in
frame with GST in the pGEX6P1 vector. GST fusion proteins were
produced in E. coli strain BL21-RIL. In vitro transcription and trans-
lation reaction of linearized plasmid was performed using a wheat-
germ extract system (Promega) in the presence of T7 RNA polymerase
and [35S]methionine. 5 lg of glutathione–agarose beads (Sigma) cou-
pled to the GST fusion proteins was incubated with 7.5 ll of TTIV
products in interaction buﬀer (50 mM Tris, pH 7.2; 10 mM MgCl2;
0.2% Tween, 0.1 mM DTT; 0.1 mM EDTA; and 150 mM NaCl).
Three washes were performed with 20 ml of 1 M NaCl and three times
with 20 ml PBS. For some clones, we did not obtain correct in vitro
transcription and translation and could not test the interaction in vitro.
2.4. Co-immunoprecipitation studies
To drive overexpression of full-length Pcdhc-b1, cDNA was fused to
a FLAG epitope in a pCAGGS vector [12] and SCG10 fused to a myc-
tag was overexpressed from a pCDNA3 vector[10]. Three 6-cm dishes
containing 2.5 · 105 COS-7 cells were transfected with 1 lg of each
plasmid. After 24 h, cells were collected by scraping in 300 ll lysis buf-
fer (50 mM Tris, pH 7, 10 mM MgCl2, and 1% Triton) in the presence
of protease inhibitor cocktail (Sigma). Lysates were incubated for 2 hat 4 C with anti-c-Myc agarose conjugate (Sigma), washed two times
in 50 mM Tris, pH 7, 150 mM NaCl, and 1% Triton buﬀer and two
times in 50 mM Tris, pH 7.4, 150 mM NaCl buﬀer and boiled for 5
min in Laemmli buﬀer prior to loading on SDS–PAGE gels.3. Results
3.1. Expression of Pcdhc-b1 protein
In order to study Pcdhc-b1 expression, we developed aﬃn-
ity-puriﬁed rabbit polyclonal antibodies directed against the
variable cytoplasmic region (Fig. 1A). On Western blots, they
recognized a 114 kDa band in the extracts of adult cerebral
cortex and COS7 cells transfected with Pcdhc-b1 (Fig. 1B).
No staining was observed in mock transfected COS-7 cells.
We used these antibodies to study the tissue and developmen-
tal expression proﬁles of Pcdhc-b1. As expected, Pcdhc-b1
levels were low compared to that of the entire Pcdhc family,
detected with a pan-Pcdhc antibody that recognizes all iso-
forms. Relative levels of Pcdhc-b1 versus pan-Pcdhc varied
between tissues (Fig. 2A). For instance, in olfactory bulb, rel-
ative levels were higher than in cortex. It is not possible to
compare the absolute intensities of Pcdhc-b1 and pan-Pcdhc
bands (Fig. 2A and B) since, to detect Pcdhc-b1, we needed
to use a more sensitive method than for pan-Pcdhc. To study
the developmental regulation of Pcdhc-b1, we followed its
expression levels in embryonic and postnatal spinal cord,
which is the tissue aﬀected in Pcdhc/ mutant mice. Pcdhc-
b1 levels in spinal cord increased from E11 to P5 but de-
creased substantially thereafter (Fig. 2B).
The weak signal detected in Western blots for Pcdhc-b1
could be due either to a low level of ubiquitous expression
or to selective expression in a subset of cells. We therefore per-
formed immunohistochemistry for Pcdhc-b1 on sections of
spinal cord from newborn mice (Fig. 2C). Whereas Pcdhc con-
stant region is expressed in the entire spinal cord (Fig. 2D),
Pcdhc-b1 expression was detected in only a limited number
of cells. The staining pattern was symmetrical between the
right and left halves of the spinal cord, suggesting that the pat-
tern reﬂects a precise regulation and is not purely stochastic.
Positive cells were found not only in the dorsal and medial
spinal cord where interneurons are localized (Fig. 2C, arrow-
heads) but also in the ventral horn. Interestingly, they are
interneurons of the medial region that degenerate in Pcdhc
knockout mice [6].3.2. Two-hybrid screen for partners of Pcdhc-b1
In order to gain insight in the cellular functions in which
Pcdhc-b1 is involved, we performed a two-hybrid screen to
identify binding partners that might be its eﬀectors. We used
as bait the 93-amino acid variable cytoplasmic domain of
Pcdhc-b1. Two million clones of a ventral spinal cord cDNA
library were screened for interactions. Plasmid DNAs encod-
ing putative interactors were isolated from the positive clones.
We co-transformed yeast again with these plasmids and with
the bait vector or several negative controls constructs as de-
scribed in Section 2. Speciﬁc interactions were conﬁrmed for
25 diﬀerent cDNAs. Eleven of the selected cDNAs encoded
unknown proteins; these were not analyzed further as
they were not expected to give information about Pcdhc-b1
function. Six other cDNAs encoded proteins predicted to be
Fig. 2. Pcdhc-b1 expression in nervous tissue. (A) Pcdhc-b1 expression in adult neural tissues, the same blot was stripped and probed with pan-
Pcdhc antibodies and ﬁnally anti-a-tubulin as a loading control. Pan-Pcdhc and Pcdhc-b1 are always co-expressed although the relative levels diﬀer
from tissue to tissue (Hb, hindbrain; Sc, spinal cord; Ob, olfactory bulb; Cb, cerebellum; Cx, cortex; Hc, hippocampus). (B) Pcdhc-b1 expression
increases during spinal cord development from embryonic day 11 (E11) to reach a peak around P5 and is only weakly downregulated thereafter. This
contrasts with pan-Pcdhc, which shows sharper variations during development. (C) Immunohistochemical detection of Pcdhc-b1 on a section of
mouse P0 spinal cord. Pcdhc-b1 is expressed only in a limited number of cells. (D) Pan-Pcdhc antibodies reveal the ubiquitous expression of Pcdhc in
the P0 spinal cord.
Fig. 3. Pcdhc-b1 variable cytoplasmic domain interacts with SCG10.
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that their interaction with the cytoplasmic domain of Pcdhc-
b1 is not likely to be biologically relevant; these were not ana-
lyzed further. The remaining clones could be classiﬁed into dif-
ferent categories according to their properties. Three of the
isolated cDNAs encoded proteins associated with axon out-
growth and guidance: SCG10, ULIP and laminin receptor 1.
Three others had a described function in RNA metabolism:
translation factor eif4g2, poly C binding protein-1 and
snRNPU5 40 kDa protein. Of the two remaining, one encoded
the intermediate ﬁlament a-internexin and the other the Pcdhc-
c4 cytoplasmic variable region.Upper panel: autoradiograph of the GST pull-down reactions. In the
ﬁrst lane, 1 ll of radiolabeled SCG10 was deposited. The following
lanes show the amounts of radiolabeled SCG10 product pulled down
by the GST protein alone or by GST fused to the variable cytoplasmic
domain of Pcdhc-b1, Pcdhc-b2, Pcdhc-b8 and Pcdhc-c4, respectively.
Lower panel: Coomassie staining of the SDS–PAGE gel shown in the
upper panel, showing the amount of GST product used in each
reaction.3.3. In vitro assay shows strong interaction of Pcdhc-b1 with
SCG10
The proteins identiﬁed in the two-hybrid screen were further
tested for their interaction with Pcdhc-b1 in an in vitro assay.
cDNAs encoding putative interactors were transcribed and
translated in vitro in the presence of radiolabeled methionine
and used for a GST pull-down assay using either a fusion pro-
tein of GST with the variable domain of Pcdhc-b1 or GST
alone. Interaction with Pcdhc-b1 was conﬁrmed for Pcdhc-c4
and the RNA binding protein polyC binding protein 1 Pcbp1.However, the strongest interaction was found for SCG10, a
microtubule-destabilizing protein found in growth cones of
neuronal cells. As shown in Fig. 3, SCG10 was retained at high
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fraction was retained by GST alone. We next asked if the inter-
action of Pcdhc-b1 with SCG10 was isoform-speciﬁc or if it
was a characteristic shared with other Pcdh isoforms. We per-
formed pull-down assays of full-length SG10 with GST fused
to either Pcdhc-b1, Pcdhc-b2, Pcdhc-b8 or Pcdhc-c4. As
shown in Fig. 3, a speciﬁc interaction was found for the b sub-
class isoforms tested, which show 34% protein sequence iden-
tity in the variable cytoplasmic domain, but not for the c4
isoform whose sequence is very divergent, nor with GST alone.
3.4. Co-immunoprecipitation of Pcdhc-b1 and SCG10 in cell
extracts
Experiments in yeast and in vitro used the variable cytoplas-
mic domain of Pcdhc-b1 fused either to GAL4 or to GST, and
thus did not reproduce the normal cellular environment of the
protein. We tested the interaction of SCG10 with the entire
Pcdhc-b1 protein after overexpression in COS7 cells. Pcdhc-
b1 was expressed as a fusion with a Flag tag and SCG10
was tagged with myc epitope. Immunoprecipitation with an
antibody to myc led to clear co-precipitation of Pcdhc-b1
(Fig. 4). We also performed the reverse experiment: immuno-
precipitation with an anti-FLAG antibody also co-precipitated
SCG10 (Fig. 4). Thus, the full-length Pcdhc-b1 isoform can
interact with SCG10 when expressed in mammalian cells.Fig. 4. Co-immunoprecipitation of PCDHc-b1 and SCG10 in COS
cells. Cos-7 cells were transfected with either Pcdhc-b1-FLAG, Pcdhc-
b1-FLAG and SCG10-myc or SCG10-myc. The upper two panels
show Western blots of the lysates. The lower panels show the
immunoprecipitation reaction performed with an anti-myc antibody
for SCG10-myc or with an anti-Flag for Pcdhc-b1-Flag. SCG10 was
detected with antibody 9E10 against myc-epitope and Pcdhc with a
pan-Pcdhc antibody.
Fig. 5. Pcdhc-b1 is found together with SCG10 in a subset of growth
cones of spinal interneurons. A growth cone of a spinal interneuron
transfected with Pcdhc-b1-myc. Pcdhc-b1 was visualized with anti-
bodies against the myc-tag (green) and endogenous SCG10 (red) using
speciﬁc antibodies.3.5. SCG10 and Pcdhc-b1 are both localized in growth cones
We previously reported the localization of Pcdhc in growth
cones of developing neurons [4]. However, the use of pan-
Pcdhc antibodies does not allow us to extrapolate this result
to the Pcdhc-b1 isoform which might have a diﬀerent localiza-
tion. As the antibodies speciﬁc for the Pcdhc-b1 isoform do
not detect endogenous protein in cultured cells, we transfected
myc-tagged Pcdhc-b1 into primary mouse spinal interneurons
and compared its localization with that of endogenous SCG10.
As shown in Fig. 5, Pcdhc-b1 and SCG10 did not colocalize in
the axon shaft but, in a subset of neurons, their ﬂuorescence
patterns in the growth cone could be superimposed, suggesting
that at some stages of the growth cone progression Pcdhc-b1
and SCG10 are appropriately placed to interact.4. Discussion
Our study is the ﬁrst to focus on the b1 isoform of Pcdhc.
We show that it is expressed in a discrete population of neu-
rons during spinal cord development. Moreover, in order to
identify downstream eﬀectors of Pcdhc-b1 protein we per-
formed a two-hybrid screen using its variable cytoplasmic do-
main as bait and identiﬁed SCG10 as a potentially relevant
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further independent assays, GST pull down and co-immuno-
precipitation. We also showed that other Pcdhc-b subtype pro-
teins, but not a c-subtype control, can interact with SCG10.
Our observations of the highly localized pattern of Pcdhc-b1
in spinal cord are in line with the work of Wang et al. [8] who
found that two individual isoforms, A11 and C4, were always
co-expressed with the constant region and, depending on the
neural tissues examined, were expressed in more or less overlap-
ping sets of cells, thus supporting the idea of combinatorial
expression patterns to distinguish neuronal subtypes. Distinct
but related promoters upstream of each variable region exon
would allow for such individual transcriptional regulation [8,9].
SCG10 is a microtubule-destabilizing protein of the stath-
min family whose expression is restricted to the nervous system
(for review, see [13]). It is associated with membranes and is
regulated through phosphorylation [14]. SCG10 and Pcdhc-
b1 show similar developmental expression proﬁles and both
localize to growth cones [15,16]. However, although Pcdhc-
b1 and SCG10 are both found in all growth cones examined,
they show close superposition only in a subset; this might re-
ﬂect a modulation of the interaction depending on the phase
of progression of the growth cone. Both Pcdhc and SCG10
are expressed at high levels in the dorsal root entry zone of
the spinal cord at developmental stages when sensory axons
tips reach this region and stop to make a long pause before
entering the spinal cord [4,15].
The interaction of Pcdhc-b1 and other members of the
Pcdhc-b subfamily with SCG10 could lead to modiﬁcations
of the microtubule cytoskeleton in response to extracellular
cues. These cues remain to be identiﬁed but could be homo-
philic interactions, as described for Pcdhc-c3 [17,18]. The loss
of this regulatory signaling would be expected to perturb neu-
rite guidance and lead to establishment of erroneous connec-
tions, as indeed observed in mice lacking the entire Pcdhc
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